GC Biopharma Products - LARVOL Sigma


Phase N/A 1 2 3 4 Trials	0	36912151821242730



Enblo (enavogliflozin) / Daewoong Pharma, GC Biopharma, M8 Pharma




Pexa-Vec (pexastimogene devacirepvec) / SillaJen, Transgene




Margenza (margetuximab-cmkb) / MacroGenics




Hepabig-gene (lenvervimab) / GC Biopharma




Hunterase (recombinant human iduronate-2-sulfatase) / GC Biopharma




MG4101 / GC Biopharma




Shinbaro (GCSB-5) / GC Biopharma, LG Chem




marzeptacog alfa (CB 813d) / GC Biopharma




Barycela (varicella II vaccine) / GC Biopharma




GC-1118A / GC Biopharma




GreenGene F (beroctocog alfa) / BMS, GC Biopharma




HyPoietin (epoetin alfa biosimilar) / GC Biopharma, Genexine, Fosun Pharma




Neulapeg (pegfilgrastim biosimilar) / GC Biopharma




AlloNK (AB-101) / GC Biopharma




GCFLU Quadrivalent (quadrivalent flu vaccine) / GC Biopharma




GC1109 / GC Biopharma




GC3107 / GC Biopharma




GCC-4401C / GC Biopharma




Green Cross TD Vaccine (GC1107) / GC Biopharma




MG-1113A / GC Biopharma




MG1109 / GC Biopharma




dalcinonacog alfa (CB2679d) / ISU Abxis, GC Biopharma




high-dose quadrivalent influenza vaccine (GC3114A) / GC Biopharma




human tonsil-derived mesenchymal stem cell (CT303) / GC Biopharma




quadrivalent cell-culture based influenza vaccine (GC3106) / GC Biopharma




AB-201 / GC Biopharma




AFM13/AB-101 / Affimed, GC Biopharma




I.V.-Globulin SN (human immune globulin intravenous) / GC Biopharma




Laennec (human placenta hydrolyzate) / GC Biopharma




Suduvax / GC Biopharma




human immunoglobulin G IV (GC5101B) / GC Biopharma




recombinant human α-galactosidase A (GC1119) / GC Biopharma



	Diseases Companies Products Productz Mechanisms of Action Sites